Simultaneous PET and Multispectral 3-dimensional Fluorescence Optical Tomography Imaging System

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2011 Aug 4

PMID 21810591

Citations 14

Authors

Changqing Li

Yongfeng Yang

Gregory S Mitchell

Simon R Cherry

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Integrated PET and 3-dimensional (3D) fluorescence optical tomography (FOT) imaging has unique and attractive features for in vivo molecular imaging applications. We have designed, built, and evaluated a simultaneous PET and 3D FOT system. The design of the FOT system is compatible with many existing small-animal PET scanners.

Methods: The 3D FOT system comprises a novel conical mirror that is used to view the whole-body surface of a mouse with an electron-multiplying charge-coupled device camera when a collimated laser beam is projected on the mouse to stimulate fluorescence. The diffusion equation was used to model the propagation of optical photons inside the mouse body, and 3D fluorescence images were reconstructed iteratively from the fluorescence intensity measurements measured from the surface of the mouse. Insertion of the conical mirror into the gantry of a small-animal PET scanner allowed simultaneous PET and 3D FOT imaging.

Results: The mutual interactions between PET and 3D FOT were evaluated experimentally. PET has negligible effects on 3D FOT performance. The inserted conical mirror introduces a reduction in the sensitivity and noise-equivalent count rate of the PET system and increases the scatter fraction. PET-FOT phantom experiments were performed. An in vivo experiment using both PET and FOT was also performed.

Conclusion: Phantom and in vivo experiments demonstrate the feasibility of simultaneous PET and 3D FOT imaging. The first in vivo simultaneous PET-FOT results are reported.

Citing Articles

Interactions between silica and titanium nanoparticles and oral and gastrointestinal epithelia: Consequences for inflammatory diseases and cancer.

Almeida-da-Silva C, Cabido L, Chin W, Wang G, Ojcius D, Li C Heliyon. 2023; 9(3):e14022.

PMID: 36938417 PMC: 10020104. DOI: 10.1016/j.heliyon.2023.e14022.

Let's embrace optical imaging: a growing branch on the clinical molecular imaging tree.

Noltes M, van Dam G, Nagengast W, van der Zaag P, Slart R, Szymanski W Eur J Nucl Med Mol Imaging. 2021; 48(13):4120-4128.

PMID: 34463808 DOI: 10.1007/s00259-021-05476-z.

Fluorescence Imaging Topography Scanning System for intraoperative multimodal imaging.

Quang T, Kim H, Bao F, Papay F, Edwards W, Liu Y PLoS One. 2017; 12(4):e0174928.

PMID: 28437441 PMC: 5402944. DOI: 10.1371/journal.pone.0174928.

Differentiation of tumor vasculature heterogeneity levels in small animals based on total hemoglobin concentration using magnetic resonance-guided diffuse optical tomography in vivo.

Kwong T, Hsing M, Lin Y, Thayer D, Unlu M, Su M Appl Opt. 2016; 55(21):5479-87.

PMID: 27463894 PMC: 6839944. DOI: 10.1364/AO.55.005479.

Multiple pinhole collimator based X-ray luminescence computed tomography.

Zhang W, Zhu D, Lun M, Li C Biomed Opt Express. 2016; 7(7):2506-23.

PMID: 27446686 PMC: 4948610. DOI: 10.1364/BOE.7.002506.

References

Culver J, Choe R, Holboke M, Zubkov L, Durduran T, Slemp A . Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging. Med Phys. 2003; 30(2):235-47. DOI: 10.1118/1.1534109. View

Garofalakis A, Zacharakis G, Meyer H, Economou E, Mamalaki C, Papamatheakis J . Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol Imaging. 2007; 6(2):96-107. View

Gambhir S, Herschman H, Cherry S, Barrio J, Satyamurthy N, Toyokuni T . Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2000; 2(1-2):118-38. PMC: 1550287. DOI: 10.1038/sj.neo.7900083. View

Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad M . Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med. 2007; 48(9):1501-10. DOI: 10.2967/jnumed.107.042234. View

Zacharakis G, Ripoll J, Weissleder R, Ntziachristos V . Fluorescent protein tomography scanner for small animal imaging. IEEE Trans Med Imaging. 2005; 24(7):878-85. DOI: 10.1109/tmi.2004.843254. View

Culver J, Akers W, Achilefu S . Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med. 2008; 49(2):169-72. DOI: 10.2967/jnumed.107.043331. View

Li C, Wang G, Qi J, Cherry S . Three-dimensional fluorescence optical tomography in small-animal imaging using simultaneous positron-emission-tomography priors. Opt Lett. 2009; 34(19):2933-5. PMC: 2856619. DOI: 10.1364/OL.34.002933. View

Ray P, De A, Min J, Tsien R, Gambhir S . Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 2004; 64(4):1323-30. PMC: 4154814. DOI: 10.1158/0008-5472.can-03-1816. View

Cherry S . Multimodality in vivo imaging systems: twice the power or double the trouble?. Annu Rev Biomed Eng. 2006; 8:35-62. DOI: 10.1146/annurev.bioeng.8.061505.095728. View

10.

Funovics M, Weissleder R, Mahmood U . Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. Radiology. 2004; 231(3):659-66. DOI: 10.1148/radiol.2313030831. View

11.

Kovar J, Volcheck W, Sevick-Muraca E, Simpson M, Olive D . Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem. 2008; 384(2):254-62. PMC: 2720560. DOI: 10.1016/j.ab.2008.09.050. View

12.

Li C, Mitchell G, Dutta J, Ahn S, Leahy R, Cherry S . A three-dimensional multispectral fluorescence optical tomography imaging system for small animals based on a conical mirror design. Opt Express. 2009; 17(9):7571-85. PMC: 2852255. DOI: 10.1364/oe.17.007571. View

13.

Ale A, Schulz R, Sarantopoulos A, Ntziachristos V . Imaging performance of a hybrid x-ray computed tomography-fluorescence molecular tomography system using priors. Med Phys. 2010; 37(5):1976-86. DOI: 10.1118/1.3368603. View

14.

Qi J, Leahy R, Cherry S, Chatziioannou A, Farquhar T . High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol. 1998; 43(4):1001-13. DOI: 10.1088/0031-9155/43/4/027. View

15.

Rowland D, Cherry S . Small-animal preclinical nuclear medicine instrumentation and methodology. Semin Nucl Med. 2008; 38(3):209-22. DOI: 10.1053/j.semnuclmed.2008.01.004. View

16.

Alexandrakis G, Rannou F, Chatziioannou A . Tomographic bioluminescence imaging by use of a combined optical-PET (OPET) system: a computer simulation feasibility study. Phys Med Biol. 2005; 50(17):4225-41. PMC: 1317109. DOI: 10.1088/0031-9155/50/17/021. View

17.

Tai Y, Chatziioannou A, Yang Y, Silverman R, Meadors K, Siegel S . MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol. 2003; 48(11):1519-37. DOI: 10.1088/0031-9155/48/11/303. View

18.

Jung J, Choi Y, Hong K, Min B, Choi J, Choe Y . Development of a dual modality imaging system: a combined gamma camera and optical imager. Phys Med Biol. 2009; 54(14):4547-59. DOI: 10.1088/0031-9155/54/14/011. View

19.

Ntziachristos V, Ripoll J, Wang L, Weissleder R . Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 2005; 23(3):313-20. DOI: 10.1038/nbt1074. View

20.

Townsend D . Multimodality imaging of structure and function. Phys Med Biol. 2008; 53(4):R1-R39. DOI: 10.1088/0031-9155/53/4/R01. View